BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20861166)

  • 21. MYC fails to efficiently shape malignant transformation in T-cell acute lymphoblastic leukemia.
    Loosveld M; Bonnet M; Gon S; Montpellier B; Quilichini B; Navarro JM; Crouzet T; Goujart MA; Chasson L; Morgado E; Picard C; Hernandez L; Fossat C; Gabert J; Michel G; Nadel B; Payet-Bornet D
    Genes Chromosomes Cancer; 2014 Jan; 53(1):52-66. PubMed ID: 24249258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells.
    Grütz GG; Bucher K; Lavenir I; Larson T; Larson R; Rabbitts TH
    EMBO J; 1998 Aug; 17(16):4594-605. PubMed ID: 9707419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?
    Rizo A; Vellenga E; de Haan G; Schuringa JJ
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R210-9. PubMed ID: 16987886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.
    Tracey LJ; Brooke-Bisschop T; Jansen PWTC; Campos EI; Vermeulen M; Justice MJ
    Mol Cancer Res; 2019 Jul; 17(7):1468-1479. PubMed ID: 31015254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of the key LMO2-binding determinants on Ldb1.
    Ryan DP; Sunde M; Kwan AH; Marianayagam NJ; Nancarrow AL; Vanden Hoven RN; Thompson LS; Baca M; Mackay JP; Visvader JE; Matthews JM
    J Mol Biol; 2006 May; 359(1):66-75. PubMed ID: 16616188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clonal evolution of leukemic stem cells in T-cell acute lymphoblastic leukemia.
    Tremblay CS; Curtis DJ
    Curr Opin Hematol; 2014 Jul; 21(4):320-5. PubMed ID: 24857886
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Wendorff AA; Quinn SA; Rashkovan M; Madubata CJ; Ambesi-Impiombato A; Litzow MR; Tallman MS; Paietta E; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Rabadan R; Van Vlierberghe P; Ferrando AA
    Cancer Discov; 2019 Mar; 9(3):436-451. PubMed ID: 30567843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis.
    Kato Y; Iwama A; Tadokoro Y; Shimoda K; Minoguchi M; Akira S; Tanaka M; Miyajima A; Kitamura T; Nakauchi H
    J Exp Med; 2005 Jul; 202(1):169-79. PubMed ID: 15998795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
    Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
    Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.
    Wu C; Li J; Tian C; Shi W; Jiang H; Zhang Z; Wang H; Zhang Q; Sun W; Sun P; Xiang R; Yang S
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2511-2525. PubMed ID: 29778661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of acute lymphoblastic leukemia.
    Teitell MA; Pandolfi PP
    Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-ALL can evolve to oncogene independence.
    Abdulla H; Vo A; Shields BJ; Davies TJ; Jackson JT; Alserihi R; Viney EM; Wong T; Yan F; Wong NC; Demoen L; Curtis DJ; Alexander WS; Van Vlierberghe P; Dickins RA; McCormack MP
    Leukemia; 2021 Aug; 35(8):2205-2219. PubMed ID: 33483615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance.
    O'Connor KW; Kishimoto K; Kuzma IO; Wagner KP; Selway JS; Roderick JE; Karna KK; Gallagher KM; Hu K; Liu H; Li R; Brehm MA; Zhu LJ; Curtis DJ; Tremblay CS; Kelliher MA
    Leukemia; 2024 May; 38(5):951-962. PubMed ID: 38553571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Lmo2 initiates T-lymphoblastic leukemia via impaired thymocyte competition.
    Abdulla HD; Alserihi R; Flensburg C; Abeysekera W; Luo MX; Gray DHD; Liu X; Smyth GK; Alexander WS; Majewski IJ; McCormack MP
    J Exp Med; 2023 Jun; 220(6):. PubMed ID: 36920307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lmo2 expression defines tumor cell identity during T-cell leukemogenesis.
    García-Ramírez I; Bhatia S; Rodríguez-Hernández G; González-Herrero I; Walter C; González de Tena-Dávila S; Parvin S; Haas O; Woessmann W; Stanulla M; Schrappe M; Dugas M; Natkunam Y; Orfao A; Domínguez V; Pintado B; Blanco O; Alonso-López D; De Las Rivas J; Martín-Lorenzo A; Jiménez R; García Criado FJ; García Cenador MB; Lossos IS; Vicente-Dueñas C; Borkhardt A; Hauer J; Sánchez-García I
    EMBO J; 2018 Jul; 37(14):. PubMed ID: 29880602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation pattern is altered in childhood T-cell acute lymphoblastic leukemia patients as compared with normal thymic subsets: insights into CpG island methylator phenotype in T-ALL.
    Kraszewska MD; Dawidowska M; Larmonie NS; Kosmalska M; Sędek Ł; Szczepaniak M; Grzeszczak W; Langerak AW; Szczepański T; Witt M;
    Leukemia; 2012 Feb; 26(2):367-71. PubMed ID: 21836607
    [No Abstract]   [Full Text] [Related]  

  • 37. [How a suppressor of tumor gets hooked of the leukaemic proliferation in man].
    Pflumio F; Kusy S; Gerby B; Roméo PH
    Med Sci (Paris); 2011 Feb; 27(2):142-3. PubMed ID: 21382322
    [No Abstract]   [Full Text] [Related]  

  • 38. ZEB2 in T-cells and T-ALL.
    De Coninck S; Berx G; Taghon T; Van Vlierberghe P; Goossens S
    Adv Biol Regul; 2019 Dec; 74():100639. PubMed ID: 31383581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL.
    Anand P; Guillaumet-Adkins A; Dimitrova V; Yun H; Drier Y; Sotudeh N; Rogers A; Ouseph MM; Nair M; Potdar S; Isenhart R; Kloeber JA; Vijaykumar T; Niu L; Vincent T; Guo G; Frede J; Harris MH; Place AE; Silverman LB; Teachey DT; Lane AA; DeAngelo DJ; Aster JC; Bernstein BE; Lohr JG; Knoechel B
    Blood; 2021 May; 137(18):2463-2480. PubMed ID: 33227818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia.
    Schubbert S; Cardenas A; Chen H; Garcia C; Guo W; Bradner J; Wu H
    Cancer Res; 2014 Dec; 74(23):7048-59. PubMed ID: 25287161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.